Staging systems for papillary thyroid carcinoma: a study of 2 tertiary referral centers
- PMID: 17592299
- PMCID: PMC1899202
- DOI: 10.1097/01.sla.0000262785.46403.9b
Staging systems for papillary thyroid carcinoma: a study of 2 tertiary referral centers
Abstract
Objective: To find out the most applicable and consistent staging system for papillary thyroid carcinoma (PTC) available in the literature.
Background: The commonly used staging systems for PTC have predicted cancer-specific survival (CSS) well. However, their applicability and generalizability have not yet been evaluated in different clinical settings.
Methods: A MEDLINE search from 1965 to 2005 was carried out to identify different staging systems available in the literature and 9 systems were applicable to 1634 PTC patients within 2 tertiary-referral centers. The CSS of each staging system within individual centers were calculated using Kaplan-Meier method and the CSS of each tumor stage in one individual center was compared with that of the other by log-rank test. In addition, within each center, the predictability of each staging system relative to the others was ranked based on the proportion of variation explained (PVE) value.
Results: Clinicopathologic features, treatment received, and tumor stages were significantly different between the 2 centers. There were also significant differences in CSS within at least one tumor stage between the 2 centers in 8 of the 9 staging systems. The TNM was a highly predictive and consistent staging system within the 2 centers. Although the absolute PVE values differed between the 2 centers, the relative ranking of the 9 staging systems within each center correlated significantly to each other (P < 0.05).
Conclusions: Despite referral, treatment, and data collection biases inherent within each center, the TNM system remained to be the most applicable and consistent staging system for PTC in 2 centers managing the same population group.
Figures
References
-
- Sherman SI. Thyroid carcinoma. Lancet. 2003;361:501–511. - PubMed
-
- Cancer incidence and mortality in Hong Kong 1983–2003. Hong Kong Cancer Registry. Available at: http://www.ha.org.hk/cancereg/stat.asp. Accessed May 15, 2006.
-
- Haselkorn T, Bernstein L, Preston-Martin S, et al. Descriptive epidemiology of thyroid cancer in Los Angeles County, 1972–1995. Cancer Causes Control. 2000;11:163–170. - PubMed
-
- Hodgson NC, Button J, Solorzano CC. Thyroid cancer: is the incidence still increasing? Ann Surg Oncol. 2004;11:1093–1097. - PubMed
-
- Reynolds RM, Weir J, Stockton DL, et al. Changing trends in incidence and mortality of thyroid cancer in Scotland. Clin Endocrinol (Oxf). 2005;62:156–162. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
